30 C
New Delhi

Molnupiravir and Paxlovid , the heavily promoted antiviral drug ,Are they really safe ?

Date:

Share post:

So many new drugs come to the market and marketed as the panacea for the illness.
History reveals many such drugs had to be withdrawn due to toxicity.

If you have practiced medicine in the last 2 to 3 decades will remember many drugs that were withdrawn due to severe adverse effects.

Cisapride was used for heartburn,flatulence got withdrawn in 2003,it was shown to cause heart rhythm disturbances

Rofecoxib was a drug prescribed right and left for arthritic pain but later shown causing more heart attacks and thus withdrawn from the market.

This drug was marketed by Merck the same company promoting Molnupiravir the anti COVID pill which has been flagged up with problems specially to pregnant women and those planning to get pregnant

Terfenadine was used for allergy drug.It was withdrawn

Rosiglitazone an anti diabetic drug had 13,000 law suits as it was shown to cause more heart attacks.

When the modern Allopathy looks at Ayurveda as herbal medicine field,the reality is long list of medicines that were used heavily in allopathy but got withdrawn due to toxicities.

Why this post now?

Molnupiravir and Paxlovid two antiviral drugs promoted heavily for the COVID but we have to be cautious that no drug is safer and doctors should exercise caution in not going overboard to prescribe to everybody( an Indian phenomenon).

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

How India’s BrahMos Became One of the World’s Most Potent Strike Weapons

India’s BrahMos supersonic cruise missile has emerged as one of the most formidable weapons in the country’s conventional...

From Import Dependence to Defence Exporter: How India Transformed Its Defence Manufacturing Capabilities in a Decade

Over the past decade, India’s defence sector has undergone a structural transformation. A country historically dependent on overseas...

How Well Did India Organize the 2026 BRICS Summit, and What Were Its Key Outcomes?

India successfully hosted the 18th BRICS Summit in New Delhi on September 12–13, 2026, at a particularly difficult...

Why and How “Hanuman Ansh” Became a New Cultural Phenomenon in India: Faith, Youth, Social Media and the Return of Spiritual Storytelling

Introduction: A ₹10-Lakh Opening That Became a Cultural Conversation Every once in a while, a film succeeds in a...